Source
stringclasses
1 value
Date
int64
2.03k
2.03k
Text
stringlengths
200
965k
Token_count
int64
40
185k
SEC
2,025
Item 2.02. Results of Operations and Financial Condition. On May 7, 2025, APA Corporation issued a press release announcing financial and operating results for the fiscal quarter ended March 31, 2025. The full text of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference. Item ...
130
SEC
2,025
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations Forward Looking Statements The following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contains forward-looking statements which relate to future events or future financial perform...
4,482
SEC
2,025
ITEM 2 . MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion relates to APA Corporation (APA or the Company) and its consolidated subsidiaries and should be read together with the Company’s Consolidated Financial Statements and accompanying notes included in ...
12,032
SEC
2,025
Item 2.02 Results of Operations and Financial Condition. On May 8, 2025, Arlo Technologies, Inc. issued a press release announcing its financial results for the first quarter ended March 30, 2025. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Item 2.02, including Exhibit 9...
227
SEC
2,025
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS ​ The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the notes thereto included in thi...
5,946
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders. Amneal Pharmaceuticals, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) on May 6, 2025. Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the An...
619
SEC
2,025
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations Forward-looking Statements This Quarterly Report on Form 10-Q (the “Quarterly Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”),...
6,274
SEC
2,025
Item 1.01 Entry into a Material Definitive Agreement Purchase Agreement On May 7, 2025, AppLovin Corporation (“AppLovin” or the “Company”) and its subsidiaries Morocco, Inc. and AppLovin GmbH (collectively, the “Sellers”) entered into a Purchase Agreement (the “Agreement”) with Tripledot (“Purchaser Parent”) and it...
2,478
SEC
2,025
Item 2 . Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion should be read in conjunction with our consolidated financial statements and the notes thereto and other financial information included elsewhere herein and in our Annual Report on Form 10-K for the...
8,109
SEC
2,025
Item 2.02 Results of Operations and Financial Condition On May 9, 2025, ANI Pharmaceuticals, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1.* Item 9.01 Exhibits (d) Exhibits ...
218
SEC
2,025
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes included elsewhere in this Q...
47,674
SEC
2,025
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the condensed consolidated financial statements (unaudited) and the accompanying notes th...
11,090
SEC
2,025
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations You should read the following discussion and analysis of our financial condition and results of operations together with the unaudited condensed consolidated financial statements and related notes that are included elsewhere...
42,736
SEC
2,025
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Except for the historical information contained herein, the matters addressed in this Item 2 constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21...
12,406
SEC
2,025
Item 5.07 Submission of Matters to a Vote The Annual Meeting of Shareholders (the "Annual Meeting") of The Andersons, Inc (the "Company") was held on May 8, 2025. At the Annual Meeting, shareholders of the Company voted on the following proposals and cast their votes as described below. Proposal 1 - The individuals...
437
SEC
2,025
Item 2. Management ’ s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis provides a narrative of our results of operations and financial condition for the three months ended March 31, 2025 and 2024. The following discussion and analysis should be read in co...
11,246
SEC
2,025
Item 7.01 Regulation FD Disclosure. On May 9, 2025, the Company made available a written presentation that management may use from time to time in connection with meetings with current and potential investors. A copy of the presentation is attached hereto as Exhibit 99.1. This Current Report on Form 8-K and the pre...
283
SEC
2,025
Item 8.01 Other Events On May 9, 2025, Artisan Partners Asset Management Inc. (the “Company”) issued a press release reporting certain information about the Company’s preliminary assets under management as of April 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by ...
197
SEC
2,025
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS ​ The following is a discussion and analysis of the consolidated operating results, financial condition, liquidity and cash flows of our company as of and for the periods presented below. The following discussion and analy...
8,026
SEC
2,025
Item 2. Management’s Discussion and Analysis o f Financial Condition and Results of Operations Ares Management Corporation is a Delaware corporation. Unless the context otherwise requires, references to “Ares,” “we,” “us,” “our,” and the “Company” are intended to mean the business and operations of Ares Management Co...
37,656
SEC
2,025
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed financial statements and related notes appearing elsewhere in this Quarte...
11,434
SEC
2,025
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Principal Accounting Officer On May 8, 2025, Amphenol Corporation (the “Company”) designated Michael R. Ivas, the Company’s Vice Presiden...
415
SEC
2,025
Item 2.02 Results of Operations and Financial Condition. On May 9, 2025, Alpha Metallurgical Resources, Inc. (the “Company”) issued a press release announcing earnings and other financial results for its fiscal quarter ended March 31, 2025. The press release is attached hereto as Exhibit 99.1. Item 5.07 Submission o...
712
SEC
2,025
Item 3.02 Unregistered Sales of Equity Securities. The disclosure under Item 8.01 below is incorporated by reference herein. The issuance of the Shares (defined below) under the Exchange Agreements (defined below) is being made pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act...
649
SEC
2,025
Item 7.01 Regulation FD Disclosure. On May 12, 2025, the Company made available on its website an updated investor presentation for use at various conferences and meetings in the coming weeks containing, among other things, certain operating statistics for April and May 2025. A copy of the investor presentation is furn...
251
SEC
2,025
Item 2.02. Results of Operations and Financial Condition. On May 8, 2025, AMN Healthcare Services, Inc. reported its results for the fiscal quarter ended March 31, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. The information in this Item 2.02, including Exh...
229
SEC
2,025
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Alexandria Real Estate Equities, Inc., a Maryland corporation (“Alexandria” or the "Company"), held its 2025 Annual Meeting of Stockholders (the “2025 Annual Mee...
1,706
SEC
2,025
Item 7.01 Regulation FD Disclosure. On May 19, 2025, Antero Resources Corporation posted an updated investor presentation on its website at www.anteroresources.com. The information furnished in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended...
135
SEC
2,025
Item 1.01 Entry into a Material Definitive Agreement. On May 16, 2025, Archrock, Inc. (“we” or “us”), Archrock Partners Operating LLC, Archrock Services, L.P. (“ASLP” and, together with Archrock Partners Operating LLC, the “Borrowers” and each, a “Borrower”) and certain of our subsidiaries entered into a Second Amendm...
811
SEC
2,025
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On May 15, 2025, the stockholders of Amphenol Corporation (the “Company”) approved an amendment to the Company’s Restated Certificate of Incorporation to amend Article FOURTH thereof to increase the number of shares of Class A Comm...
975
SEC
2,025
Item 1.01. Entry into a Material Definitive Agreement. The information provided in Item 2.03 below is hereby incorporated herein by reference. Item 1.02. Termination of a Material Definitive Agreement. The information provided in Item 2.03 below is hereby incorporated herein by reference. Item 2.03. Creation of a...
1,315
SEC
2,025
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. As further described in Item 5.07 below, at the 2025 Annual Meeting of Shareholders (the “Annual Meeting”) of APi Group Corporation (the “Company”) held on May 16, 2025, upon the recommendation of the Company’s Board of Directors, the...
1,031
SEC
2,025
Item 2.02 Results of Operations and Financial Condition On May 20, 2025, Nikhil Lalwani, President & CEO of ANI Pharmaceuticals, Inc., will present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference in New York, New York. A copy of the investor presentation is attached as Exhibit 99.1 hereto and incorpo...
267
SEC
2,025
Item 7.01 Regulation FD Disclosure. On May 21, 2025, APi Group Corporation (the “Company”) issued a press release announcing, among other things, certain long-term financial targets and a dividend of one-half of one share of common stock for each share of common stock held of record as of the close of business on Jun...
237
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders At Artivion, Inc.’s (the “Company” or “Artivion”) 2025 Annual Meeting of Stockholders held on May 13, 2025 (the “Annual Meeting”), Artivion’s stockholders elected each individual that was nominated for election as director of the Company to serve until the...
753
SEC
2,025
Item 7.01 Regulation FD Disclosure. On May 21, 2025, AutoNation, Inc. (the “Company”) issued a press release announcing the closing of a $700.0 million asset-backed securitization transaction. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished purs...
513
SEC
2,025
Item 5.07. Submission of Matters to a Vote of Security Holders. At the Annual Meeting of Stockholders of Amkor Technology, Inc. (the “Company”) held on May 15, 2025, the following proposals were voted on by the stockholders of the Company. The proposals are described in detail in the Company’s definitive proxy statem...
660
SEC
2,025
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. On May 21, 2025, Amazon.com, Inc. (the “Company”) held its Annual Meeting of Shareholders. The following nominees were elected as directors, each to hold office until the next Annual Meeting of Shareholders or until his or her successor is elected...
1,098
SEC
2,025
Item 7.01 Regulation FD Disclosure. Athene Holding Ltd. (“Athene”), a subsidiary of Apollo Global Management, Inc., will host a Fixed Income Investor call today, May 12, 2025 at 10:00 a.m. ET. The call will feature members of Athene’s senior management team, who will provide an update on current business trends, n...
306
SEC
2,025
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On May 21, 2025, the Board of Directors (the "Board") of American Woodmark Corporation (the "Company") received notice from Mr. James G. Davis, Jr. that he had de...
196
SEC
2,025
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Apple Hospitality REIT, Inc. Employee Stock Purchase Plan As described below in Item 5.07 of this Current Report on Form 8-K, on May 19, 2025, the shareholder...
1,065
SEC
2,025
Item 1.01.   Entry into a Material Definitive Agreement. On May 20, 2025 (the “ Amendment No. 8 Effective Date ”), APi Group DE, Inc. (the “ Borrower ”), a wholly owned subsidiary of APi Group Corporation (the “ Company ”) entered into and closed the transactions contemplated by that certain Amendment No. 8 to Credit...
2,181
SEC
2,025
Item 3.02 Unregistered Sales of Equity Securities. The disclosure under Item 8.01 below is incorporated by reference herein. The issuance of the Shares (defined below) under the Exchange Agreements (defined below) was made pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), o...
558
SEC
2,025
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On May 29, 2025 , the Registrant issued a press release announcing results for its fourth quarter of fiscal year 2025 ended April 30, 2025. The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. ITEM 9.01 FINANCIAL STATEMENTS...
130
SEC
2,025
Item 1.01   Entry into a Material Definitive Agreement. On May 30, 2025, American Tower Corporation (the “Company”) completed a registered public offering of 500.0 million euros (“EUR”) aggregate principal amount of its 3.625% senior unsecured notes due 2032 (the “notes”), which resulted in aggregate net proceeds to ...
1,303
SEC
2,025
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers (b) On May 22, 2025, Raelyn A. Trende tendered her resignation as Chief Human Resources Officer of Apogee Enterprises, Inc. (the “Company”), effective as of June...
108
SEC
2,025
Item 2.02 Results of Operations and Financial Condition. On May 28, 2025, Abercrombie & Fitch Co. (the “Company”) issued a news release (the “Release”) reporting the Company’s unaudited financial results for the first quarter ended May 3, 2025. A copy of the Release is included as Exhibit 99.1 to this Current Report ...
696
SEC
2,025
ITEM 5.07 Submission of Matters to a Vote of Security Holders. On May 30, 2025, Arista Networks, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). The stockholders voted on the following proposals at the Annual Meeting: 1. To elect three Class II directors to serve until the ...
459
SEC
2,025
Item 8.01 Other Events. On May 21, 2025, American Tower Corporation issued a press release (the “Press Release”) announcing that it had priced its registered public offering of senior unsecured notes due 2032 (the “2032 notes”) in an aggregate principal amount of 500.0 million euros. The 2032 notes will have an int...
184
SEC
2,025
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers ANI Pharmaceuticals, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) on May 22, 2025. At the Annual Meeting, the stockhol...
1,921
SEC
2,025
Item 5.07. Submission of Matters to a Vote of Security Holders. Apellis Pharmaceuticals, Inc. (the “Company”) held its Annual Meeting of Stockholders on June 3, 2025. The following is a summary of the matters voted on at that meeting. (a) The stockholders of the Company elected A. Sinclair Dunlop, Alec Machiels...
528
SEC
2,025
Item 5.07. Submission of Matters to a Vote of Security Holders At the annual meeting of shareholders of APA Corporation (the “Company”) held on May 22, 2025, there were 361,441,463 shares of the Company’s common stock, par value $0.625 per share, eligible to vote, of which 315,519,427 shares, or approximately 87%, we...
673
SEC
2,025
Item 4.01 Changes in Registrant’s Certifying Accountant. Dismissal of Independent Registered Public Accounting Firm On November 19, 2024, the Audit Committee of the Board of Directors of Alpha and Omega Semiconductor Limited (the “Company”) approved the dismissal of Baker Tilly US, LLP (“ Baker Tilly”) as the Company...
990
SEC
2,025
Item 1.01 Entry into a Material Definitive Agreement. On June 3, 2025, Artisan Partners Holdings LP (“Holdings”), of which Artisan Partners Asset Management Inc. is the sole general partner, entered into a Note Purchase Agreement (the “Agreement”) with the note purchasers named therein, a number of which are also par...
895
SEC
2,025
ITEM 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. ​ At the 2025 Annual Meeting of Stockholders of Amphastar Pharmaceuticals, Inc. (the “Company”) held on June 2, 2025 (the “Annual Meeting”), the stockholders of the Company voted on and approved amendments to the Company’s Amended ...
1,403
SEC
2,025
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 4, 2025, the employment of D. Clay Bretches, Executive Vice President of Operations of APA Corporation, was terminated.
61
SEC
2,025
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Election of Craig A. Wheeler to the Board of Directors On April 17, 2025, the Board of Directors (the “Board”) of Apellis Pharmaceuticals, Inc. (the “Company”)...
898
SEC
2,025
Item 2.02 Results of Operations and Financial Condition On June 4, 2025, Nikhil Lalwani, President & CEO of ANI Pharmaceuticals, Inc., will present at the Jefferies Global Healthcare Conference in New York, New York. A copy of the investor presentation is attached as Exhibit 99.1 hereto and incorporated herein by ref...
259
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders On June 4, 2025, AppLovin held its annual meeting of stockholders (the “Meeting”). The stockholders of the Company voted on the following two proposals at the Meeting, each of which is more fully described in the Company’s definitive proxy statement filed ...
662
SEC
2,025
Item 5.07. Submission of Matters to a Vote of Security Holders. Annual Meeting . On June 6, 2025, Apollo Global Management, Inc. (the “ Company ”) held its 2025 Annual Meeting of Stockholders (the “ Annual Meeting ”). The matters voted upon at the Annual Meeting and the final results of such voting are set forth below....
786
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders. On June 4, 2025, at the annual meeting of stockholders (the “Annual Meeting”) of Antero Resources Corporation (the “Company”), the Company’s stockholders were requested to (i) elect three Class III members of the Board to serve until the Company’s 2028 an...
448
SEC
2,025
Item 7.01 Regulation FD Disclosure. On June 11, 2025, the Company issued a press release announcing it recently completed the acquisition of a Homewood Suites by Hilton in Tampa, Florida. A copy of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein solely for pur...
236
SEC
2,025
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 6, 2025, AMERISAFE, Inc. (the “Company”) held its 2025 annual meeting of shareholders (the “2025 Annual Meeting”). At the 2025 Annual Meeting, as furthe...
936
SEC
2,025
Item 1.01 Entry into a Material Definitive Agreement. On June 9, 2025, Amphenol Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and between the Company and Citigroup Global Markets Inc., Mizuho Securities USA LLC and TD Securities (USA) LLC , as representatives of ...
436
SEC
2,025
Item 8.01. Other Events. On June 9, 2025, Air Products and Chemicals, Inc. (the “Company”) entered into an Underwriting Agreement (the “U.S. Underwriting Agreement”) with Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC and Wells Fargo Securities, LLC, as r...
1,447
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders. Annual Meeting of Stockholders On June 6, 2025, Ares Management Corporation (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). The issued and outstanding shares of stock of the Company entitled to vote at the Annual Meeting ...
905
SEC
2,025
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read together with the Company’s Condensed Consolidated Financial Statements and Notes to Condensed Conso...
11,219
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders. The 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of American Tower Corporation (the “Company”) was held virtually on May 14, 2025. At the Annual Meeting, the Company's stockholders elected eleven individuals to the Board of Directors (the “B...
732
SEC
2,025
Item 1.01 Entry into a Material Definitive Agreement. On June 11, 2025, Amphenol Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and between the Company and BNP PARIBAS , Citigroup Global Markets Limited, Commerzbank Aktiengesellschaft, Barclays Bank PLC, HSBC Bank...
537
SEC
2,025
ITEM 7.01 – REGULATION FD DISCLOSURE ArcBest ® (Nasdaq: ARCB) is providing an update on the most recent information related to its second quarter 2025 financial results and business trends. ​ Summary Operating and Financial Impacts ● Statistics for May 2025 are preliminary and not yet finalized. ● There were 21....
2,296
SEC
2,025
Item 8.01 Other Events On June 10, 2025, Artisan Partners Asset Management Inc. (the “Company”) issued a press release reporting certain information about the Company’s preliminary assets under management as of May 31, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by ...
197
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders. At the Annual Meeting of Stockholders of Abercrombie & Fitch Co. (the “Company”) held on June 11, 2025 by means of remote communication (the “Annual Meeting”), the Company’s stockholders considered and voted on the matters listed below, each of which is d...
693
SEC
2,025
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On June 11, 2025, Paul Joachimczyk, Senior Vice President and Chief Financial Officer of American Woodmark Corporation (the “Company”), provided his resignation f...
243
SEC
2,025
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 17, 2025, Rebecca A. Hoyt, senior vice president, Chief Accounting Officer, and Controller, informed APA Corporation (the “Company”) of her intention to ...
103
SEC
2,025
ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 13, 2025 , Arista Networks, Inc. (the “Company”) appointed Todd Nightingale, age 45, to serve as the Company’s President and Chief Operating Officer. Mr....
1,000
SEC
2,025
Item 1.01 Entry into a Material Definitive Agreement. On June 16, 2025, Amphenol Corporation (the “Company”) issued and sold €600,000,000 aggregate principal amount of the Company’s 3.125% Senior Notes due 2032 (the “Notes”), pursuant to the Company’s Registration Statement on Form S-3 (No. 333-270605), including the...
1,100
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders. On June 20, 2025 , Arlo Technologies, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). As of April 21, 2025, the record date for the Annual Meeting, 103,711,343 shares of common stock were outstanding and entitled ...
429
SEC
2,025
Item 1.01 Entry into a Material Definitive Agreement. On July 1, 2025 (the “Closing Date”), Apellis Pharmaceuticals, Inc. and its subsidiaries Apellis International GmbH and APL DEL Holdings, LLC (collectively, the “Company”) entered into a Royalty Buy-Down Agreement (the “Royalty Agreement”) with Swedish Orphan Biov...
408
SEC
2,025
Item 1.01 Entry into a Material Definitive Agreement On June 30, 2025, AppLovin Corporation (“AppLovin”) and Tripledot (“Purchaser Parent”) entered into an amendment (the “Amendment”) to that certain Purchase Agreement, dated as of May 7, 2025 by and among AppLovin, its subsidiaries Morocco, Inc. and AppLovin GmbH (c...
511
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders. The Annual Meeting of Stockholders (the “Annual Meeting”) of Apollo Commercial Real Estate Finance, Inc. (the “Company”) was held on June 10, 2025, at which 106,619,312 shares of the Company’s common stock were represented in person or by proxy representi...
615
SEC
2,025
Item 2.02 Results of Operations and Financial Condition. The information contained in Item 7.01 of this Current Report on Form 8-K under the heading “Preliminary Estimates for Alternative Net Investment Income” is hereby incorporated by reference into this Item 2.02. Item 7.01 Regulation FD Disclosure. Preliminary...
934
SEC
2,025
ITEM 1.01 – ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT ​ The information required by Item 1.01 is included in Item 2.03 and is incorporated by reference herein. ​ ITEM 2.03 – CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT ​ ​ On June 12, 2025,...
898
SEC
2,025
Item 1.01. Entry into a Material Definitive Agreement. The information provided in Item 2.03 below is hereby incorporated herein by reference. Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On June 27, 2025, Amkor Technology, Inc. (the ...
677
SEC
2,025
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 30, 2025, the board of directors (the “Board”) of Apollo Global Management, Inc. (the “Company”) approved the appointment of Kristiane Kinahan as Chief A...
360
SEC
2,025
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 2, 2025, the Board of Directors of the Company appointed Peter Crawford to serve on the Board and to join the Board’s Audit Committee. Mr. Crawford mos...
296
SEC
2,025
Item 5.07 Submission of Matters to a Vote of Security Holders. The Company's Annual Meeting of Shareholders (the "Annual Meeting") was held on June 25, 2025. The three proposals voted upon at the Annual Meeting are described in detail in the Company’s Proxy Statement for the Annual Meeting filed with the Securities...
366
SEC
2,025
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 7, 2025, Sean D. Major resigned as Executive Vice President, General Counsel and Secretary of Air Products and Chemicals, Inc. (the “Company”), effectiv...
158
SEC
2,025
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS (e) On July 1, 2025, the Compensation Committee (the “Committee”) of the Board of Directors of American Woodmark Corporation (the “Company”) approved special rete...
463
SEC
2,025
Item 7.01 Regulation FD Disclosure. On May 30, 2025, the Company made available on its website an updated investor presentation for use at various conferences and meetings in the coming weeks containing, among other things, certain operating statistics for April and May 2025. A copy of the investor presentation is furn...
251
SEC
2,025
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Amendment to International Assignment Letter On June 27, 2025, Aon Corporation (“Aon Corporation”), an indirect, wholly owned subsidiary of Aon plc (together w...
1,461
SEC
2,025
Item 1.01 Entry into a Material Definitive Agreement. On July 14, 2025, Alpha & Omega Semiconductor Limited (“AOS Bermuda”) and its subsidiary, Alpha & Omega Semiconductor (Shanghai) Ltd. (“AOS Shanghai” and collectively, the “Company”) entered into an equity transfer agreement (the “Agreement”) with certain strategi...
669
SEC
2,025
Item 2.02 Results of Operations and Financial Condition. On July 21, 2025, Amneal Pharmaceuticals, Inc. (the “Company”) issued a press release announcing certain unaudited preliminary financial results for the second quarter ended June 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and incor...
617
SEC
2,025
ITEM 5.02 – DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On July 17, 2025, ArcBest Corporation (the “Company”) issued a press release announcing that Judy R. McReynolds, the current chief executive officer and chairm...
633
SEC
2,025
Item 8.01 Other Events. On July 21, 2025, Amneal Pharmaceuticals, Inc. (the “Company”) announced that its subsidiary, Amneal Pharmaceuticals LLC (the “Issuer”), is seeking to borrow $1,800 million of new seven-year term B loans (the “new term B loans”) under a new term loan facility and has launched an offering of $7...
492
SEC
2,025
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers . ​ On July 18, 2025, the Board of Directors (the “Board”) of Amphastar Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Nominating and Co...
477
SEC
2,025
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations Forward-looking statements This Quarterly Report on Form 10-Q, including the section, Management’s Discussion and Analysis of Financial Condition and Results of Operations, contains certain statements that are considered “...
6,829
SEC
2,025
Item 1. BUSINESS Our Company American Woodmark Corporation ("American Woodmark," the "Company," "we," "our" or "us") was incorporated in 1980 by the four principal managers of the Boise Cascade Cabinet Division through a leveraged buyout of that division. We operated privately until 1986 when we became a public ...
19,277
SEC
2,025
Item 2.02 Results of Operations and Financial Condition. On July 23, 2025, ANI Pharmaceuticals, Inc. (the “Company”) is announcing select preliminary unaudited financial results for the second quarter ended June 30, 2025. The Company expects combined ILUVIEN ® and YUTIQ ® net revenues of $22.3 million for the three m...
497
SEC
2,025
Item 8.01 Other Events. On July 23, 2025, the Company issued a press release and held a conference call announcing the results of the NEW DAY Study. A copy of the presentation that the Company used at the conference call to discuss the NEW DAY Study results is attached hereto as Exhibit 99.1 and is incorporated herei...
125
SEC
2,025
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Forward-looking statements Certain information and statements included in this quarterly report on Form 10-Q, including, without limitation, statements containing the words “forecast,” “guidance,” “goals,” “projects,” “e...
65,206